Molecular minimal residual disease in resected non-small cell lung cancer: “flattening the curve”

Authors

Institutions

Publication Details

Journal
Translational Lung Cancer Research
Published
2025-10-01
DOI
https://doi.org/10.21037/tlcr-2025-642
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular minimal residual disease in resected non-small cell lung cancer: “flattening the curve”

Marc G. Denis
Translational Lung Cancer Research
Lung Cancer Treatments and Mutations
article

Molecular minimal residual disease in resected non-small cell lung cancer: “flattening the curve”

Marc G. Denis
article en

Abstract

No abstract available for this paper.
Translational Lung Cancer ResearchVol. 14(10)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR), Nantes Université (FR)
Openalex Percentile: Top 55%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Molecular minimal residual disease in resected non-small cell lung cancer: “flattening the curve” — Marc G. Denis · Translational Lung Cancer Research (2025) | TGRS Research Map | TGRS